Morgan Stanley’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.8M | Buy |
|
|||||
|
2025
Q1 | $4.35M | Buy |
|
|||||
|
2024
Q4 | $4.14M | Sell |
|
|||||
|
2024
Q3 | $6.11M | Sell |
|
|||||
|
2024
Q2 | $4.22M | Buy |
|
|||||
|
2024
Q1 | $374K | Buy |
|
|||||
|
2023
Q4 | $323K | Buy |
|
|||||
|
2023
Q3 | $102K | Sell |
|
|||||
|
2023
Q2 | $147K | Sell |
|
|||||
|
2023
Q1 | $516K | Buy |
|
|||||
|
2022
Q4 | $13.6K | Sell |
|
|||||
|
2022
Q3 | $51K | Sell |
|
|||||
|
2022
Q2 | $103K | Sell |
|
|||||
|
2022
Q1 | $337K | Buy |
|
|||||
|
2021
Q4 | $511K | Buy |
|
|||||
|
2021
Q3 | $323K | Buy |
|
|||||
|
2021
Q2 | $269K | Buy |
|